A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

NCT00605722 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: bevacizumab (Avastin)
DRUG: erlotinib (Tarceva)

Sponsor

Hoffmann-La Roche